Literature DB >> 35785432

Development of myelinating glia: An overview.

Carlo D Cristobal1,2, Hyun Kyoung Lee1,2,3,4.   

Abstract

Myelin is essential to nervous system function, playing roles in saltatory conduction and trophic support. Oligodendrocytes (OLs) and Schwann cells (SCs) form myelin in the central and peripheral nervous systems respectively and follow different developmental paths. OLs are neural stem-cell derived and follow an intrinsic developmental program resulting in a largely irreversible differentiation state. During embryonic development, OL precursor cells (OPCs) are produced in distinct waves originating from different locations in the central nervous system, with a subset developing into myelinating OLs. OPCs remain evenly distributed throughout life, providing a population of responsive, multifunctional cells with the capacity to remyelinate after injury. SCs derive from the neural crest, are highly dependent on extrinsic signals, and have plastic differentiation states. SC precursors (SCPs) are produced in early embryonic nerve structures and differentiate into multipotent immature SCs (iSCs), which initiate radial sorting and differentiate into myelinating and non-myelinating SCs. Differentiated SCs retain the capacity to radically change phenotypes in response to external signals, including becoming repair SCs, which drive peripheral regeneration. While several transcription factors and myelin components are common between OLs and SCs, their differentiation mechanisms are highly distinct, owing to their unique lineages and their respective environments. In addition, both OLs and SCs respond to neuronal activity and regulate nervous system output in reciprocal manners, possibly through different pathways. Here, we outline their basic developmental programs, mechanisms regulating their differentiation, and recent advances in the field.
© 2022 The Authors. GLIA published by Wiley Periodicals LLC.

Entities:  

Keywords:  CNS and PNS development; Remak cells; Schwann cells; myelination; oligodendrocytes

Mesh:

Substances:

Year:  2022        PMID: 35785432      PMCID: PMC9561084          DOI: 10.1002/glia.24238

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   8.073


  274 in total

1.  Fluorescent proteins expressed in mouse transgenic lines mark subsets of glia, neurons, macrophages, and dendritic cells for vital examination.

Authors:  Yi Zuo; Jane L Lubischer; Hyuno Kang; Le Tian; Michelle Mikesh; Alexander Marks; Virginia L Scofield; Shan Maika; Craig Newman; Paul Krieg; Wesley J Thompson
Journal:  J Neurosci       Date:  2004-12-08       Impact factor: 6.167

2.  Glial growth factor restricts mammalian neural crest stem cells to a glial fate.

Authors:  N M Shah; M A Marchionni; I Isaacs; P Stroobant; D J Anderson
Journal:  Cell       Date:  1994-05-06       Impact factor: 41.582

3.  Origin of oligodendrocytes within the human spinal cord.

Authors:  M Hajihosseini; T N Tham; M Dubois-Dalcq
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

4.  N-WASp is required for Schwann cell cytoskeletal dynamics, normal myelin gene expression and peripheral nerve myelination.

Authors:  Fuzi Jin; Baoxia Dong; John Georgiou; Qiuhong Jiang; Jinyi Zhang; Arjun Bharioke; Frank Qiu; Silvia Lommel; M Laura Feltri; Lawrence Wrabetz; John C Roder; Joel Eyer; Xiequn Chen; Alan C Peterson; Katherine A Siminovitch
Journal:  Development       Date:  2011-04       Impact factor: 6.868

5.  In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice.

Authors:  P Ye; J Carson; A J D'Ercole
Journal:  J Neurosci       Date:  1995-11       Impact factor: 6.167

6.  Membrane-bound neuregulin1 type III actively promotes Schwann cell differentiation of multipotent Progenitor cells.

Authors:  Rainer Leimeroth; Christian Lobsiger; Agnes Lüssi; Verdon Taylor; Ueli Suter; Lukas Sommer
Journal:  Dev Biol       Date:  2002-06-15       Impact factor: 3.582

7.  Neuronal activity biases axon selection for myelination in vivo.

Authors:  Jacob H Hines; Andrew M Ravanelli; Rani Schwindt; Ethan K Scott; Bruce Appel
Journal:  Nat Neurosci       Date:  2015-04-06       Impact factor: 24.884

8.  Playing the field: Sox10 recruits different partners to drive central and peripheral myelination.

Authors:  Ben Emery
Journal:  PLoS Genet       Date:  2013-10-31       Impact factor: 5.917

Review 9.  The repair Schwann cell and its function in regenerating nerves.

Authors:  K R Jessen; R Mirsky
Journal:  J Physiol       Date:  2016-03-21       Impact factor: 5.182

10.  Transforming growth factors-beta 1 and beta 2 are mitogens for rat Schwann cells.

Authors:  A J Ridley; J B Davis; P Stroobant; H Land
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

View more
  1 in total

1.  Molecular and Regenerative Characterization of Repair and Non-repair Schwann Cells.

Authors:  Tomoaki Suzuki; Ken Kadoya; Takeshi Endo; Norimasa Iwasaki
Journal:  Cell Mol Neurobiol       Date:  2022-10-12       Impact factor: 4.231

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.